Blackstone

Ovid eyes next chapter with CEO transition—Chutes & Ladders

Ovid's Levin set to become chairman as its next CEO stands ready. FDA’s oncology head takes top CDER post. Metagenomi shuffles CEO in reorg. Plus more.

Darren Incorvaia , Zoey Becker Nov 14, 2025 8:30am

graphic image of different colored hands shaking

Merck bags $700M from Blackstone, spends $150M to regain asset

Nov 4, 2025 9:15am

puzzle pieces merger and acquisition business concept

Hologic to go private with $18.3B deal by Blackstone and TPG

Oct 22, 2025 8:45am

Blackstone buys majority stake in CMIC, Japan's largest CRO

Mar 4, 2025 2:37pm

pass the torch deal sell buy acquisition

Novartis inks $925M Anthos takeover to rejoin clot-busting race

Feb 11, 2025 5:21am

Blackstone unsheathes Uniquity Bio with $300M

May 15, 2024 11:00am